{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T21:03:54Z","timestamp":1768511034340,"version":"3.49.0"},"posted":{"date-parts":[[2024,4,20]]},"group-title":"Cancer Biology","reference-count":56,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,4,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Breast cancer (BC) is the most prevalent cancer worldwide and is accompanied by fatigue during both active disease and remission in the majority of cases. Our lab has measured fatigue in isolated muscles from treatment-naive BC patient-derived orthotopic xenograft (BC-PDOX) mice. Here, we conducted a preclinical trial of pioglitazone in BC-PDOX mice to determine its efficacy in ameliorating BC-induced muscle fatigue, as well as its effects on transcriptomic, metabolomic, and lipidomic profiles in skeletal muscle.<\/jats:p>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>\n                    The pioglitazone and vehicle groups were treated orally for 4 weeks upon reaching a tumor volume of 600 mm\n                    <jats:sup>3<\/jats:sup>\n                    . Whole-animal indirect calorimetry was used to evaluate systemic metabolic states. The transcriptome was profiled using short-read bulk RNA sequencing (RNA-seq). Liquid chromatography-tandem mass spectrometry (LC-MS\/MS) was used to profile the metabolome and lipidome. Fast and slow skeletal muscle function were evaluated using isolated\n                    <jats:italic>ex vivo<\/jats:italic>\n                    testing.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Pioglitazone was associated with a significant overall decrease in metabolic rate, with no changes in substrate utilization. RNA-seq supported the downstream effects of pioglitazone on target genes and displayed considerable upregulation of mitochondrial bioenergetic pathways. Skeletal muscle metabolomic and lipidomic profiles exhibited dysregulation in response to BC, which was partially restored in pioglitazone-treated mice compared to vehicle-treated BC-PDOX mice. Despite molecular support for pioglitazone\u2019s efficacy, isolated muscle function was not affected by pioglitazone treatment.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>BC induces multi-omic dysregulation in skeletal muscle, which pioglitazone partially ameliorates. Future research should focus on profiling systemic metabolic dysfunction, identifying molecular biomarkers of fatigue, and testing alternative pioglitazone treatment regimens.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Statement of Translational Relevance<\/jats:title>\n                  <jats:p>Breast cancer-induced fatigue is a prevalent and debilitating symptom that affects a majority of patients, leading to early treatment discontinuation and poorer outcomes. Despite its significant impact on patient quality of life, there are currently no approved therapies for this condition. Our previous work in the clinically relevant breast cancer patient-derived orthotopic xenograft (BC-PDOX) mouse model suggests that disruptions in the PPAR\u03b3 signaling pathway may contribute to the development of cancer-related fatigue. Using this model that recapitulates the fatigue phenotype observed in patients, we conducted a preclinical trial evaluating the FDA-approved PPAR\u03b3 agonist, pioglitazone, as a treatment for fatigue. Our multi-omic analysis of skeletal muscle from BC-PDOX mice revealed that pioglitazone treatment partially restored dysregulated lipid profiles and mitochondrial bioenergetic transcriptomic alterations. These findings suggest that pioglitazone may have potential as a therapeutic option for managing cancer-related fatigue in breast cancer patients.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2024.04.15.589557","type":"posted-content","created":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T23:18:09Z","timestamp":1713655089000},"source":"Crossref","is-referenced-by-count":2,"title":["Preclinical Multi-Omic Assessment of Pioglitazone in Skeletal Muscles of Mice Implanted with Human HER2\/neu Overexpressing Breast Cancer Xenografts"],"prefix":"10.64898","author":[{"given":"Stuart A.","family":"Clayton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan D.","family":"Mizener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcella","family":"Whetsell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren E.","family":"Rentz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan","family":"Meadows","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Geldenhuys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emidio E.","family":"Pistilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024042313400825000_2024.04.15.589557v1.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"2024042313400825000_2024.04.15.589557v1.2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21754"},{"key":"2024042313400825000_2024.04.15.589557v1.3","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-20301-6_4"},{"key":"2024042313400825000_2024.04.15.589557v1.4","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-020-0707-5"},{"key":"2024042313400825000_2024.04.15.589557v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2007.08.012"},{"key":"2024042313400825000_2024.04.15.589557v1.6","first-page":"e693458","article-title":"Estimation of Cachexia among Cancer Patients Based on Four Definitions","volume":"2009","year":"2009","journal-title":"J Oncol"},{"key":"2024042313400825000_2024.04.15.589557v1.7","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-006-9447-x"},{"key":"2024042313400825000_2024.04.15.589557v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2014.11.002"},{"key":"2024042313400825000_2024.04.15.589557v1.9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0306981100"},{"key":"2024042313400825000_2024.04.15.589557v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)00269-1"},{"key":"2024042313400825000_2024.04.15.589557v1.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7827(01)00005-4"},{"key":"2024042313400825000_2024.04.15.589557v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/0959-437X(95)80025-5"},{"key":"2024042313400825000_2024.04.15.589557v1.13","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.2007.S60"},{"key":"2024042313400825000_2024.04.15.589557v1.14","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1565"},{"issue":"2","key":"2024042313400825000_2024.04.15.589557v1.15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/rco2.69","article-title":"Rescue of a peroxisome proliferator activated receptor gamma gene network in muscle after growth of human breast tumour xenografts","volume":"5","year":"2022","journal-title":"JCSM Rapid Commun"},{"key":"2024042313400825000_2024.04.15.589557v1.16","doi-asserted-by":"crossref","unstructured":"Wilson HE , Stanton DA , Rellick SL , Geldenhuys WJ , Pistilli EE . Breast cancer-associated skeletal muscle mitochondrial dysfunction and lipid accumulation is reversed by PPARG. Am J Physiol-Cell Physiol. 2021;320(4).","DOI":"10.1152\/ajpcell.00264.2020"},{"issue":"2","key":"2024042313400825000_2024.04.15.589557v1.17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13539-011-0030-x","article-title":"Intramyocellular lipid droplets increase with progression of cachexia in cancer patients","volume":"2","year":"2011","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2024042313400825000_2024.04.15.589557v1.18","doi-asserted-by":"publisher","DOI":"10.1038\/25931"},{"key":"2024042313400825000_2024.04.15.589557v1.19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.17.7921"},{"key":"2024042313400825000_2024.04.15.589557v1.20","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.30.18779"},{"key":"2024042313400825000_2024.04.15.589557v1.21","doi-asserted-by":"publisher","DOI":"10.2165\/11538100-000000000-00000"},{"key":"2024042313400825000_2024.04.15.589557v1.22","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0201-4"},{"key":"2024042313400825000_2024.04.15.589557v1.23","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btt656"},{"key":"2024042313400825000_2024.04.15.589557v1.24","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-018-2201-7"},{"key":"2024042313400825000_2024.04.15.589557v1.25","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp616"},{"key":"2024042313400825000_2024.04.15.589557v1.26","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-1-r1"},{"key":"2024042313400825000_2024.04.15.589557v1.27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-10-1"},{"key":"2024042313400825000_2024.04.15.589557v1.28","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty528"},{"key":"2024042313400825000_2024.04.15.589557v1.29","unstructured":"Clayton SA , Mizener AD , Rentz LE , Pistilli E. CLAMS Wrangler: a python program for preprocessing data generated by the Comprehensive Laboratory Animal Monitoring System [Internet]. Zenodo; 2024 [cited 2024 Apr 3]. Available from: https:\/\/zenodo.org\/records\/10914556"},{"issue":"4","key":"2024042313400825000_2024.04.15.589557v1.30","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cmet.2018.06.019","article-title":"CalR: A Web-Based Analysis Tool for Indirect Calorimetry Experiments","volume":"28","year":"2018","journal-title":"Cell Metab"},{"issue":"1","key":"2024042313400825000_2024.04.15.589557v1.31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41523-020-0162-2","article-title":"Skeletal muscle reprogramming by breast cancer regardless of treatment history or tumor molecular subtype","volume":"6","year":"2020","journal-title":"NPJ Breast Cancer"},{"key":"2024042313400825000_2024.04.15.589557v1.32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI44945"},{"key":"2024042313400825000_2024.04.15.589557v1.33","doi-asserted-by":"publisher","DOI":"10.1007\/s00360-014-0857-5"},{"key":"2024042313400825000_2024.04.15.589557v1.34","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1988.sp017279"},{"key":"2024042313400825000_2024.04.15.589557v1.35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7793.2001.00591.x"},{"issue":"4","key":"2024042313400825000_2024.04.15.589557v1.36","doi-asserted-by":"crossref","first-page":"C704","DOI":"10.1152\/ajpcell.00122.2021","article-title":"Dystrophin-negative slow-twitch soleus muscles are not susceptible to eccentric contraction induced injury over the lifespan of the mdx mouse","volume":"321","year":"2021","journal-title":"Am J Physiol-Cell Physiol"},{"issue":"1","key":"2024042313400825000_2024.04.15.589557v1.37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.metabol.2004.07.008","article-title":"Effect of pioglitazone on body composition and energy expenditure: a randomized controlled trial","volume":"54","year":"2005","journal-title":"Metab - Clin Exp"},{"key":"2024042313400825000_2024.04.15.589557v1.38","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0428"},{"key":"2024042313400825000_2024.04.15.589557v1.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2014.06.008"},{"issue":"4","key":"2024042313400825000_2024.04.15.589557v1.40","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/jdi.12606","article-title":"Pioglitazone improves whole-body aerobic capacity and skeletal muscle energy metabolism in patients with metabolic syndrome","volume":"8","year":"2017","journal-title":"J Diabetes Investig"},{"key":"2024042313400825000_2024.04.15.589557v1.41","doi-asserted-by":"crossref","first-page":"154416","DOI":"10.1016\/j.metabol.2020.154416","article-title":"Pioglitazone corrects dysregulation of skeletal muscle mitochondrial proteins involved in ATP synthesis in type 2 diabetes","volume":"114","year":"2021","journal-title":"Metabolism"},{"key":"2024042313400825000_2024.04.15.589557v1.42","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M112.021162"},{"issue":"6","key":"2024042313400825000_2024.04.15.589557v1.43","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/jcsm.12626","article-title":"High levels of modified ceramides are a defining feature of murine and human cancer cachexia","volume":"11","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2024042313400825000_2024.04.15.589557v1.44","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.5.1215"},{"issue":"Suppl 10","key":"2024042313400825000_2024.04.15.589557v1.45","first-page":"101","article-title":"Effects of pioglitazone and high-fat diet on ceramide metabolism in rat skeletal muscles","volume":"57","year":"2006","journal-title":"J Physiol Pharmacol Off J Pol Physiol Soc"},{"key":"2024042313400825000_2024.04.15.589557v1.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2003.08.020"},{"key":"2024042313400825000_2024.04.15.589557v1.47","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-198901000-00010"},{"key":"2024042313400825000_2024.04.15.589557v1.48","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1974.sp010540"},{"key":"2024042313400825000_2024.04.15.589557v1.49","doi-asserted-by":"crossref","unstructured":"van Someren KA . Chapter 5 - The physiology of anaerobic endurance training. In: Whyte G , Spurway N , MacLaren D , Cracknell J , editors. The Physiology of Training [Internet]. Edinburgh: Churchill Livingstone; 2006 [cited 2024 Mar 20]. p. 85\u2013115. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780443101175500106","DOI":"10.1016\/B978-0-443-10117-5.50010-6"},{"key":"2024042313400825000_2024.04.15.589557v1.50","first-page":"905612","article-title":"Interaction among Skeletal Muscle Metabolic Energy Systems during Intense Exercise","volume":"2010","year":"2010","journal-title":"J Nutr Metab"},{"issue":"4","key":"2024042313400825000_2024.04.15.589557v1.51","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/jcsm.12294","article-title":"Dysregulation of metabolic-associated pathways in muscle of breast cancer patients: preclinical evaluation of interleukin-15 targeting fatigue","volume":"9","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2024042313400825000_2024.04.15.589557v1.52","doi-asserted-by":"publisher","DOI":"10.4103\/0976-0105.177703"},{"key":"2024042313400825000_2024.04.15.589557v1.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2015.10.004"},{"key":"2024042313400825000_2024.04.15.589557v1.54","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003388"},{"key":"2024042313400825000_2024.04.15.589557v1.55","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007725"},{"issue":"1","key":"2024042313400825000_2024.04.15.589557v1.56","first-page":"168","article-title":"Structures of PPAR\u03b3 complexed with lobeglitazone and pioglitazone reveal key determinants for the recognition of antidiabetic drugs","volume":"7","year":"2017","journal-title":"Sci Rep"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.04.15.589557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:18:37Z","timestamp":1768457917000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2024.04.15.589557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,20]]},"references-count":56,"URL":"https:\/\/doi.org\/10.1101\/2024.04.15.589557","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.3390\/cancers16213640","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,4,20]]},"subtype":"preprint"}}